BioAtla (BCAB) EBT Margin Growth (1y) (2021)
BioAtla (BCAB) EBT Margin Growth (1y) (2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,342.66 Bn | 67,342.38 Bn | - | - |
| 2 | Nanobiotix | 1,887.92 Bn | 1,887.86 Bn | - | - |
| 3 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn | 1,526.00 |
| 4 | Vertex Pharmaceuticals | 122.57 Bn | 115.32 Bn | 2.59 Bn | 1,558.00 |
| 5 | Regeneron Pharmaceuticals | 69.18 Bn | 60.43 Bn | 3.31 Bn | -683.00 |
| 6 | Belite Bio | 61.55 Bn | 61.55 Bn | - | - |
| 7 | Argenx Se | 56.68 Bn | 51.50 Bn | 1.41 Bn | 452.00 |
| 8 | Revolution Medicines | 37.83 Bn | 37.83 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 36.81 Bn | 33.80 Bn | 959.66 Mn | 1,939.00 |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -1.55 Mn |